Indicated for the triage and notification of obstructive hydrocephalus on non-contrast brain computed tomography (CT), the artificial intelligence (AI)-enabled software is reportedly the first radiology triage modality to obtain the Food and Drug Administration’s (FDA) Breakthrough Device Designation.
The Food and Drug Administration (FDA) has granted 510(k) clearance for a new artificial intelligence (AI) software that may facilitate earlier brain CT detection and triage of the potentially life-threatening condition of obstructive hydrocephalus (OHCP).
Based on assessment of non-contrast brain CT scans, the AI software provides passive and active notifications on suspected cases of OHCP, according to Annalise.ai, the developer of the software. The company noted that the OHCP software is the first triage device in radiology to receive the FDA’s Breakthrough Device Designation.
The FDA clearance of the OHCP software is the 10th FDA clearance for the company’s AI-powered software applications, including five software applications that can be utilized for head CT scans, according to Annalise.ai.
“Our advanced algorithms support radiologists by facilitating prioritization of non-contrast head CT studies with suspected critical findings, thereby optimizing radiology workflow,” noted Rick Abramson, the chief medical officer at Annalise.ai. “With its set of clearances, Annalise.ai promotes faster report turnaround times by identifying and elevating critical cases for immediate attention.”
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.